Poseida Therapeutics Overview
Poseida Therapeutics Discounted Cash Flow
DCF Analysis for PSTX.
Get informed when a big investor buys or sells
+ FollowFair Value
$-6.30
Current Fair Value
$-6.30
↓ 166.3% Downside
Overvalued by 166.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison